Merck's Plans for Chemists, the FDA, and Upcoming Deals
January 15, 2014
January 15, 2014 | Matthew Herper gets Merck on the phone to discuss strategy, the FDA, and organizational changes. Forbes
CII uses cookies to improve your website & conference experiences, including enhancing website navigation, personalized features & promotions, evaluating our services, and customizing content and ads based on your preferences as you browse or engage with us. By clicking "Continue" or continuing to use our site, you are agreeing to our and our partners use of cookies. See our Privacy Policy for more information.